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Abstract
Background: The HIV epidemic in sub-Saharan Africa has had a major impact on infectious
disease, and there is currently great interest in the impact of HIV on intestinal barrier function. A
three year longitudinal cohort study in a shanty compound in Lusaka, Zambia, carried out before
anti-retroviral therapy was widely available, was used to assess the impact of HIV on susceptibility
to intestinal infectious disease. We measured the incidence and seasonality of intestinal infection
and diarrhoea, aggregation of disease in susceptible individuals, clustering by co-habitation and
genetic relatedness, and the disease-to-infection ratio.
Methods: Adults living in a small section of Misisi, Lusaka, were interviewed every two weeks to
ascertain the incidence of diarrhoea. Monthly stool samples were analysed for selected pathogens.
HIV status and CD4 count were determined annually.
Results: HIV seroprevalence was 31% and the prevalence of immunosuppression (CD4 count 200
cells/μL or less) was 10%. Diarrhoea incidence was 1.1 episodes per year and the Incidence Rate
Ratio for HIV infection was 2.4 (95%CI 1.7–3.3; p < 0.001). The disease-to-infection ratio was
increased at all stages of HIV infection. Aggregation of diarrhoea in susceptible individuals was
observed irrespective of immunosuppression, but there was little evidence of clustering by co-
habitation or genetic relatedness. There was no evidence of aggregation of asymptomatic
infections.
Conclusion: HIV has an impact on intestinal infection at all stages, with an increased disease-to-
infection ratio. The aggregation of disease in susceptible individuals irrespective of CD4 count
suggests that this phenomenon is not a function of cell mediated immunity.
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Background
Intestinal infection causing diarrhoeal disease is a domi-
nant contributor to high death rates and developmental
retardation in developing countries [1]. Most of the mor-
bidity and mortality due to diarrhoea is in young children,
but in the wake of the HIV pandemic, diarrhoea and sec-
ondary malnutrition emerged as a major problem in
adults too, especially in sub-Saharan Africa [2]. The epide-
miology of intestinal infectious disease is complex, with
over 30 viruses, bacteria or protozoa being implicated in
its aetiology [3]. Although widespread uptake of highly
active anti-retroviral therapy (HAART) in urban Zambia
[4] has reduced the burden of diarrhoeal disease in adults
despite the continuing high prevalence of HIV, people
with AIDS-related diarrhoea still present to hospitals and
clinics, and mortality in such cases is still high. Before the
anti-retroviral era, and regrettably still in many parts of
the continent, the HIV epidemic created populations in
which a significant proportion of the community was
immunosuppressed at any one time, but the implications
of this degree of population immunosuppression for the
impact of intestinal pathogens was not defined. It was
never clear whether advanced immunosuppression makes
intestinal disease inevitable in adults living in the most
environmentally deprived conditions. Nor was it estab-
lished whether in such populations the immunosuppres-
sion led to increased infection with diarrhoea-causing
pathogens, or to increased disease manifestations in carri-
ers of pathogens. Understanding alterations in risk of
infection and risk of disease help understand the nature of
the immunological defect.
We set up a longitudinal cohort study in an impoverished
population in Misisi, Lusaka [5] in order to determine the
incidence of intestinal infection and the proportion of
such infections associated with diarrhoeal disease. As the
cohort was fairly representative of a particular commu-
nity, it was possible to analyse the phenomenon of aggre-
gation. It is well known that intestinal helminth infections
display aggregation [6-8] meaning that certain susceptible
individuals carry large numbers of worms and therefore a
disproportionate fraction of the burden of disease [9].
There is also some evidence that incidence of diarrhoeal
disease is aggregated in some highly susceptible children
[10,11] and adults [12] in an analogous way. In this paper
we analyse diarrhoea and infection separately which
allows us to demonstrate that the disease-to-infection
ratio is elevated at all stages of HIV infection. We also
show that diarrhoea incidence displays aggregation in
both immunocompetent and immunosuppressed Zam-
bian adults.
Recently there has been great interest in the impact of HIV
on the gut [13], both because of virally-induced T cell
depletion [14-16], and because intestinal damage may
drive bacterial translocation and hence immune activa-
tion [17]. The recognition that the gut is an important tar-
get organ for HIV lends great urgency to an understanding
of the functional change in immune function both in
early and late stage disease. On balance, most morpho-
metric [5,18-21] and functional [5,22-24] evidence sug-
gests that intestinal damage (enteropathy) is largely a
feature of late HIV disease. Our study design also allowed
us to analyse the stage of HIV disease at which susceptibil-
ity to infection changes.
Methods
Study setting
A cohort study of diarrhoea and intestinal infection was
carried out in Misisi compound, an unplanned residential
area in the southern part of Lusaka which was illegal until
1995 and where sanitation is rudimentary, housing is of
poor quality, and overcrowding is intense. Mortality rates
in adults are high [25], probably attributable to the sever-
ity of the HIV epidemic. In Lusaka the HIV seroprevalence
is probably static at around 22% [26]. Authorisation was
obtained to study part of one sector of Misisi from the
Lusaka Urban District Health Management Board, and
approval was obtained from the Research Ethics Commit-
tees of the University of Zambia and the London School
of Hygiene and Tropical Medicine. The study was set up in
April 1999, and the cohort followed until May 2002. At
this time anti-retroviral therapy and co-trimoxazole
prophylaxis were not standard of care and not given to the
study cohort.
The study included only residents in a defined area.
Recruitment of a cohort within a cluster of closely
grouped houses was felt to be important to maximise
retention in the study and to increase the probability that
residents would share a similar degree of exposure to
enteric pathogens. Drinking water in this area is drawn
from only 20 standpipes, and sanitation is provided by 25
pit latrines. Food is obtained from a small number of local
markets. At the outset, a house to house survey was con-
ducted to include all households in the study area, during
which the purpose of the study was explained, and one
respondent per household was interviewed to obtain a
demographic profile. Every adult resident (18 years of age
or more) was then invited to the nearest urban health cen-
tre, a 10 minute walk from the study area, for interview
and examination. At this interview, the purpose of the
study was explained in more detail and a two page infor-
mation sheet read out in one of four local languages. This
information included explicit description (including pho-
tographs) of the procedures involved in participating in
the study over three years. The recruitment and consent
process included information about HIV testing, and par-
ticipants who consented to inclusion in the study were
offered the option of HIV testing (together with CD4BMC Gastroenterology 2009, 9:7 http://www.biomedcentral.com/1471-230X/9/7
Page 3 of 11
(page number not for citation purposes)
count) with full pre- and post-test counselling, but they
were also free not to have the test.
At the initial interview, questions were also asked about
the source of drinking water habitually used, about how
often and when drinking is boiled, about alternative
sources of drinking water, and whether water drunk out-
side the home is boiled. Nutritional assessment included
weight and height (combined into the body mass index in
kg/m2) and serum retinol concentration measured by
high performance liquid chromatography at the mid-
point of the study as one of several potential markers of
micronutrient status. At the mid-point of the study, the
nurses were asked to score each household for hygiene
facilities and practices in the home, as previously
described [5]. A scale of 1–10 was used, up to 2 points
being given for each of the following: overall cleanliness
of the house, water storage facilities, food storage facili-
ties, hand-washing facilities and their use, and sanitation
facilities.
Each participant was interviewed every two weeks using a
standardised questionnaire and asked to report any epi-
sodes of diarrhoea in the previous two weeks. Two defini-
tions of diarrhoea were used: either a subjective report of
symptoms as previously described [27], or the presence of
increased water in stool samples. They also provided a
stool sample at some point during each month if there
were no symptoms, or whenever there was diarrhoea.
Only one sample was analysed each month; if diarrhoea
supervened during the month and an 'asymptomatic'
sample had already been submitted the diarrhoea sample
result was used in its place. These samples were trans-
ported to the laboratory by 09.30 each day and processed
immediately. Participants were also treated for any medi-
cal problems. Every year, subjects were counselled and
offered an HIV test, and a CD4 count was performed irre-
spective of HIV status if consent was given.
In the laboratory, stool consistency (a measure of water
content) was noted and protozoa and helminths identi-
fied in each sample by microscopy of a wet preparation, a
Ziehl-Neelsen stained thin smear, and a very thin smear
stained with Sianongo's modified trichrome stain [28].
Swabs which had been stabbed into Cary-Blair transport
medium in the field clinic prior to transport to the hospi-
tal laboratory were used to inoculate MacConkey, xylose-
lactose-sucrose, sorbitol-MacConkey, Yersinia selective
and thiosulphate-citrate-bile salt agar plates. Colonies of
non-lactose fermenting bacteria were subjected to bio-
chemical characterisation using triple-sugar-iron, lysine-
iron, sulphide-indole-motility, urea and Simmons citrate
media, and interpreted using Cowan & Steel's manual
[29]. Isolates picked at random were confirmed using the
API 20E system. Micro-aerophilic conditions for isolation
of  Campylobacter jejuni were difficult to maintain and
results for this organism are omitted.
In order to analyse the disease-to-infection ratio (i.e. the
proportion of infection episodes which lead to diar-
rhoea), two definitions of intestinal infections were used.
The restrictive definition included only infections associ-
ated with diarrhoea in this study (C. parvum, I. belli,
microsporidia, G. intestinalis, S. stercoralis, V. cholerae). A
more open definition included the first group together
with other bacteria commonly associated with diarrhoea
(Salmonella spp., Shigella spp., A. hydrophila).
Data analysis
We analysed incidence of diarrhoea and of infection sep-
arately. For both diarrhoea and infection, each month was
evaluated separately. Analysis of the records of diarrhoea
month-by-month reveals that diarrhoea episodes of over
4 days duration could not have overlapped for more than
9 participants, and months of diarrhoea can therefore be
regarded as separate episodes. Analysis with these partici-
pants excluded did not alter the results which include
these participants. To determine whether incidence of
intestinal infection could be distorted by persistent infec-
tions, the proportion of infectious episodes which could
have overlapped into consecutive months was also ana-
lysed. At most, 11% of episodes of cryptosporidiosis, 10%
of giardiasis and 1% of salmonellosis could have over-
lapped. Omission of these potentially non-incident epi-
sodes increased the disease-to-infection ratio from 18.4%
to 18.8%, so we conclude that it is valid to consider each
month as a discrete and independent period of observa-
tion.
The seasonality of diarrhoeal disease and of infections was
assessed by grouping monthly data into six 2-month peri-
ods. Disease-to-infection ratio [30] was calculated as the
proportion of months in which an intestinal infection was
identified during which diarrhoea was reported. For the
association between diarrhoea (defined either subjec-
tively or by water content of stool samples) and pathogen
infections, odds ratios (OR) were calculated and Mantel-
Haenszel stratification used to adjust for HIV status.
Fisher's exact and chi-squared tests were used to test the
strength of these associations.
To analyse clustering of diarrhoea and infection, we
excluded participants who had submitted less than 10
months of data. A negative binomial model was con-
structed and the value of alpha (a measure of aggregation)
was used to describe clustering in susceptible individuals
(i.e.aggregation). The model was then used (with a term
to account for aggregation) to relate the incidence of diar-
rhoea to age, sex, HIV status, CD4 count below 200 cells/
μL, body mass index below the median, serum retinolBMC Gastroenterology 2009, 9:7 http://www.biomedcentral.com/1471-230X/9/7
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concentration below the median, water boiling practices,
and the household hygiene index. The negative binomial
model was also used to compare the effect of clustering
between individuals, for household co-habitation
(defined as eating together) and first-degree genetic relat-
edness (i.e. parent/child or sibling relationships). Data
analysis was performed using STATA 8.2 (Stata Corp, Col-
lege Station, Texas).
Results
In April 1999 the initial house-to-house survey identified
506 adults as resident in the study area [31]. Of these, 270
(53%) consented to participate in the study, and 206
(76%, 41% of all residents) actively participated in the
follow-up and are included in this analysis (Table 1). After
one year, 174 (84%) remained, 148 (72%) after two years,
and at the close of the third year, 121 (59%) were still
included. By April 2002, 20 (9.7%) participants had died
during the 3 years of follow-up. The majority of losses to
follow up were due to moving house, usually to obtain
better housing, to return to the family village, or to avoid
rent arrears. Mean follow-up was 22.8 months.
At recruitment, 177 of 206 participants underwent HIV
testing, and 53 (30%) were seropositive (Table 1). A fur-
ther 11 participants were tested later in the study and of
these 5 were seropositive when tested, making a total of
58 (31%) positive of those tested at some point. Of these
58, 6 were incident infections. Overall, 17 (33%) of 52
HIV seropositive participants at recruitment had CD4
counts under 200 cells/μL (one test failed for technical
reasons). This represents 10% (17/177) of all the adults in
this population who were willing to participate. None of
the HIV seronegative participants had CD4 counts below
200 cells/μL.
Incidence of diarrhoea and intestinal infection
From the 206 subjects, a total of 5,199 person-months of
observation were completed. Diarrhoea was reported in
488 months, and 4,711 months were diarrhoea-free, giv-
ing an overall incidence of 0.094 episodes per month or
1.1 episodes per year. In HIV seronegatives the rate was
0.068 per month and in HIV seropositives the rate was
0.153 per month.
A total of 4,780 stool samples were submitted for analysis,
and results for bacteria, protozoa or helminths obtained
in 4,731 (99%) samples. Mixed infections (with the path-
ogens defined above) were found in 12 samples. The pres-
ence of pathogens by stool consistency is shown in Table
2. Certain parasites (I. butschlii, C. mesnili, A. lumbricoides,
and E. nana) were less frequently detected in more watery
stools, consistent with a lack of pathogenicity. Infections
with C. parvum, I. belli, and G. intestinalis were associated
with increasing water content of the stool samples, and
Table 1: Demographic and clinical characteristics of 206 study participants
Male Female
n 70 136
Age (median, IQR) 38 (31–49) 31 (25–40)
Age (range) 21–74 18–79
HIV seropositive at baseline 14/60 (23%) 39/117 (33%)
Seroconverted to HIV during follow-up 2 4
CD4 count (cells/μl) if HIV positive (median, IQR) (range) 210 (125–432) (40–929) 299 (177–399) (51–810)
CD4 count (cells/μl) if HIV negative (median, IQR) (range) 742 (583–797) (269–1184) 812 (664–1001) (384–1623)
BMI (kg/m2) (median, IQR) 19.7 (18.1–21.5) 21.7 (19.9–24.6)
BMI below 18.5 kg/m2 25/75 (33%) 18/124 (15%)
Serum retinol (μmol/l) (median, IQR) 1.91 (1.52–2.41) 1.62 (1.30–2.08)
Hygiene score (median, IQR) 3 (2–5) 2 (2–6)
IQR, interquartile range; CD4, cluster differentiation antigen 4; HIV, human immunodeficiency virus; BMI, body mass index. P value refers to 
Kruskal-Wallis test of difference between medians, or Fisher's exact test of difference between proportions.BMC Gastroenterology 2009, 9:7 http://www.biomedcentral.com/1471-230X/9/7
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these associations were all stronger after Mantel-Haenszel
stratification for HIV status (data not shown).
For 4,294 (91%) samples the pathogen results were
related to the HIV status of the individual. C. parvum, I.
belli, and C. rodentium infections were significantly com-
moner in HIV-infected adults (Table 3). Certain non-
pathogenic protozoa and helminths were less common in
HIV-infected participants (Table 3), possibly due to self-
treatment with antimicrobials and anti-helminthics.
Table 2: Frequency of intestinal infection in relation to stool consistency
Organism Formed Soft Loose Watery p trend
n = 2194 n = 2230 n = 290 n = 17
Cryptosporidium parvum 16 (0.8) 34 (1.5) 7 (2.4) 0 0.02 0.004
Isospora belli 8 (0.4) 4 (0.2) 7 (2.4) 1 (5.9) < 0.001 0.001
Microsporidia 3 3 1 0 ns
Giardia intestinalis 16 (0.7) 33 (1.5) 9 (3.1) 2 (11.8) < 0.001 < 0.001
Blastocystis hominis 144 150 30 1 ns
Entamoeba histolytica 11 8 0 0 ns
Iodamoeba butschlii 108 (4.9) 53 (2.4) 8 (2.8) 0 < 0.001 < 0.001
Entamoeba hartmanii 35 25 2 0 ns
Chilomastix mesnili 173 (7.9) 138 (6.2) 6 (2.1) 0 0.001 < 0.001
Ascaris lumbricoides 383 (17.5) 326 (14.6) 37 (12.8) 0 0.007 0.001
Hookworm 76 63 7 1 ns
Strongyloides stercoralis 4 (0.2) 8 (0.4) 3 (1) 0 0.1 0.04
Schistosoma mansoni 11 10 2 0 ns
Endolimax nana 212 (9.7) 143 (6.4) 11 (3.8) 0 < 0.001 < 0.001
Hymenolepis nana 16 12 0 0 ns
Trichuris trichiura 16 0 0 n s
Taenia saginata 36 2 0 n s
Salmonella spp. 24 31 3 0 ns
Shigella spp. 9 7 2 0 ns
Aeromonas hydrophila 98 0 0 n s
Citrobacter rodentium 417 406 61 3 ns
Vibrio cholerae 32 1 0 n s
Percentages are shown in brackets where significant differences were found. 'P' was derived by Fisher's exact test across all groups, 'trend' refers to 
the P value using the χ2 for trend test to detect progressive changes in frequency with trends in consistency.BMC Gastroenterology 2009, 9:7 http://www.biomedcentral.com/1471-230X/9/7
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There was clear seasonal variation in the incidence both of
diarrhoea and of some infections. The incidence of Crypt-
osporidium parvum, Endolimax nana, Iodamoeba butschlii,
Strongyloides stercoralis, Hymenolepis nana, Shigella spp.,
Aeromonas hydrophila and Citrobacter rodentium infections
was seasonal, but the pattern of seasonality differed (Fig
1). Infections with Isospora belli, Giardia intestinalis, Blasto-
cystis hominis, Ascaris lumbricoides, hookworm, Chilomastix
mesnili, and Salmonella spp. were not seasonal. The sea-
sonal variation in diarrhoea incidence was evident in both
HIV seropositive and seronegative participants.
Association between infection and reported symptoms of 
diarrhoea
For 4,198 (89%) samples the pathogen results could be
related to the presence or absence of diarrhoea reported
within two weeks of the date submitted, and associations
shown in Table 4. There were few infections which were
clearly associated with diarrhoea, and the majority of
infections detected, even with known pathogens, were
asymptomatic. Infection with I. belli, microsporidia, or V.
cholerae were significantly associated with diarrhoea after
stratification by HIV status: the respective Mantel-Haen-
szel Odds Ratios were 5.9 (95% CI 2.0–16.8; p = 0.0002),
9.1 (1.6–53; p = 0.002) and 13 (1.8–94; p = 0.001).
The overall risk of intestinal infection for pathogens asso-
ciated with diarrhoea (Fig 2A) and other potential diar-
rhoeal pathogens (Fig 2B) was higher only in those with
low CD4 counts. However the disease-to-infection ratio
was elevated for HIV seropositive participants irrespective
of CD4 count whether using the restrictive definition (Fig
2C) or the more open definition of pathogen (Fig 2D).
Clustering, susceptibility and resistance
Clustering of incidence (i.e. aggregation) was analysed in
192 participants, as those with under 10 months of obser-
vation were excluded. Diarrhoea incidence was over-dis-
persed in both HIV seropositive (α = 0.263; p < 0.0001)
and HIV seronegative adults (α = 0.983; p < 0.0001), and
in adults with CD4 counts of less than 200 cells/μL (α =
0.48; p = 0.001). In a negative binomial model the diar-
rhoea incidence rate ratio for HIV infection was 2.4
(95%CI 1.7–3.3; p < 0.001).
At an individual level the degree of clustering could be
quite pronounced, with some adults experiencing fre-
quent diarrhoea. Conversely, within the group of HIV
seropositive participants, certain individuals were appar-
ently resistant to diarrhoea. These included a 34-year old
woman with a CD4 count of 52 who experienced no diar-
rhoea at all in 26 months of follow-up. Also a 29-year old
woman with a CD4 count of 109 who experienced no
diarrhoea in 36 months of follow up. Three other women
(CD4 counts of 399, 444 and 451) experienced no diar-
rhoea at all.
Allowing for the clustering of diarrhoea in individuals, the
incidence of diarrhoea was related independently to the
presence of HIV infection (IRR 2.2, 95%CI 1.5–3.2; p <
0.001), not to immunosuppression per se, and to the
housing hygiene index below the median (IRR 1.7, 95%CI
1.2–2.4; p = 0.002). There was no evidence of clustering
of diarrhoea by household co-habitation nor by genetic
relatedness. Diarrhoea incidence was not reduced in fam-
ilies which reported that they boil water.
Table 3: Frequency of intestinal infection in relation to HIV
Organism HIV+ HIV- P HIV positive HIV positive
n = 1313 n = 2981 CD4 < 200
cells/μl
CD4 > 200
cells/μl
C. parvum 36 (2.7) 18 (0.6) < 0.001 25 6
I. belli 13 (1.0) 7 (0.2) 0.002 8 1
I. butschlii 29 (2.2) 130 (4.4) < 0.001 7 13
C. mesnili 69 (5.3) 220 (7.4) 0.01 26 29
A. lumbricoides 172 (13.1) 520 (17.4) < 0.001 48 72
S. stercoralis 01 4  ( 0 . 5 ) 0 . 0 0 8 - -
C. rodentium 265 (22.7) 465 (17.8) 0.001 65 138
Only infections which differ significantly with HIV status are shown. P values derived by Fisher's exact test.BMC Gastroenterology 2009, 9:7 http://www.biomedcentral.com/1471-230X/9/7
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Conversely, there was no evidence of clustering of infec-
tion with pathogens, either using the restrictive definition
(α = 10-14; p = 1.0) or the more open definition (α = 10-
11; p = 1.0).
Discussion
Although many studies of diarrhoeal disease in AIDS in
Africa were done in the pre-HAART era, there is little com-
munity-based information on the changes in susceptibil-
ity to intestinal infections and diarrhoea in relation to
stage of HIV disease. The data presented here indicate that
adults living with HIV/AIDS in the pre-HAART era were at
increased risk of diarrhoeal disease, with a rate ratio of
2.4. This increased risk was not confined to adults with
low CD4 count, and was predominantly due to an
increase in the disease-to-infection ratio at all stages of
HIV infection. There was also an increase in the risk of
infections, whether or not associated with diarrhoea,
when the CD4 count fell below 200 cells/μL. We have pre-
viously shown that it is predominantly in this latter group
that nutritional impairment is found [31], and it is in this
group that enteropathy is predominantly found [5]. We
conclude that HIV leads to T cell dysfunction even in its
earliest stages, leading to increased risk of diarrhoea when
infections occur, but the increased susceptibility to infec-
tion occurs later in the course of HIV infection, which is
the time when enteropathy supervenes. Taken together,
our current and previous studies [5,18] suggest that enter-
opathy in Zambian adults is a consequence of the
increased susceptibility to intestinal infection which
occurs in the later stages of HIV infection, and is therefore
Seasonal variation in diarrhoea and in eight intestinal infections Figure 1
Seasonal variation in diarrhoea and in eight intestinal infections. The seasons (each of 2 months) are shown along the 
x axis (1 May, June; 2 July, August; 3 September, October; 4 November, December; 5 January, February; 6 March, April) and 
the incidence of that infection per 'season' on the y axis. Rainfall is November-March, so shigellosis is commoner in the dry sea-
son and aeromoniasis during the rains. Infections which are listed in Table 1 and not shown here did not display seasonality.
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unlikely to be a driver of HIV disease progression in the
earlier stages as Douek's hypothesis would suggest [13].
In this study, there was clear evidence of clustering (i.e.
aggregation) of diarrhoeal disease over time in certain
individuals, indicating that some people are more suscep-
tible to diarrhoea than others. This confirms and extends
observations made before the HIV pandemic [10-12].
Interestingly, this aggregation of disease is still seen in
severely immunosuppressed adults with CD4 counts of
less than 200 cells/μL, so it seems unlikely to be attribut-
able to variations in cell-mediated immunity. Humoral
Table 4: Frequency of intestinal infection in relation to recalled diarrhoea
Organism Frequency (%) in months when diarrhoea reported
n = 408
Frequency (%) in months when diarrhoea not reported
n = 3790
P
Cryptosporidium parvum 11 (2.7) 38 (1.0) 0.006
Isospora belli 7 (1.7) 13 (0.3) 0.002
Microsporidia 3 (0.7) 5 (0.1) 0.035
Giardia intestinalis 7 (1.7) 47 (1.2) ns
Blastocystis hominis 31 (7.6) 249 (6.6) ns
Entamoeba histolytica 01 3  ( 0 . 3 ) n s
Iodamoeba butschlii 13 (3.2) 142 (3.8) ns
Entamoeba hartmanii 4 (1.0) 53 (1.4) ns
Chilomastix mesnili 30 (7.3) 250 (6.6) ns
Ascaris lumbricoides 68 (16.7) 585 (15.4) ns
Hookworm 14 (3.4) 108 (2.9) ns
Strongyloides stercoralis 1 (0.3) 12 (0.3) ns
Schistosoma mansoni 2 (0.5) 16 (0.4) ns
Endolimax nana 31 (7.6) 291 (7.7) ns
Hymenolepis nana 1 (0.3) 23 (0.6) ns
Trichuris trichiura 0 6 (0.2) ns
Taenia saginata 0 8 (0.2) ns
Salmonella spp. 5 (1.3) 46 (1.3) ns
Shigella spp. 2 (0.5) 12 (0.3) ns
Aeromonas hydrophila 3 (0.8) 13 (0.4) ns
Citrobacter rodentium 86 (23.1) 786 (22.5) ns
Vibrio cholerae 2 (0.5) 3 (0.1) 0.08
Frequency of detection of protozoa, helminths and bacteria in stool samples submitted by study participants each month. Months of observation 
were categorised as with or without diarrhoea based on recall of symptoms every two weeks. P determined by Fisher's exact test. ns, not 
significant.BMC Gastroenterology 2009, 9:7 http://www.biomedcentral.com/1471-230X/9/7
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(antibody-mediated) immunity does not seem to play a
major role in defence against intracellular pathogens
(such as C. parvum, I. belli, or the microsporidia), so we
postulate that susceptibility and resistance are determined
by variations in innate immunity, possibly genetic. We
were unable to demonstrate clustering of incidence rates
in first-degree relatives in this cohort, but genetic studies
would have to be much larger to have the power to dissect
out the influence of genetic variation. While we observed
clustering of incidence of diarrhoea over time in suscepti-
ble individuals, this was not observed for intestinal infec-
tion with potential pathogens. This probably means that
the increased incidence of diarrhoea in these susceptible
adults is not due to an increased risk of colonisation. We
are then left to postulate that it is due to an inability to
control the intensity of infection (leading to increased dis-
ease-to-infection ratio) or to prevent the expression of vir-
ulence factors.
In a study of this nature, ascertainment of symptoms may
be a problem, even when the study cohort is under close
supervision as it was in our study. We recruited partici-
pants from a small number of houses on one contiguous
area within Misisi township, a very disadvantaged residen-
tial area, for two reasons. The first reason was to approxi-
mate to the assumption of uniform exposure to diarrhoea-
causing organisms. The second reason was to ensure effec-
tive follow-up of the participants so that disclosure of
symptoms would be as full as possible. While we cannot
be sure that every episode of diarrhoea was recorded, we
Risk of intestinal infection and diarrhoeal disease in the whole cohort, and according to HIV status and CD4 count Figure 2
Risk of intestinal infection and diarrhoeal disease in the whole cohort, and according to HIV status and CD4 
count. Fig 2A shows the absolute risk of intestinal infection per month, irrespective of symptoms, for pathogens using the 
restrictive definition (see Methods), and Fig 2B shows the absolute risk of infection per month, irrespective of symptoms, using 
the more open definition. Fig 2C shows the percentage of intestinal infections associated with diarrhoea (i.e. disease-to-infec-
tion ratio) using the restrictive definition. Fig 2D shows the disease-to-infection ratio using the more open definition.
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have only analysed months of follow-up in which a given
participant was interviewed and asked directly about
whether they had experienced diarrhoea in the previous
two weeks. Our reliance on reported symptoms of diar-
rhoea also introduces the difficulty of ascertaining when
episodes become persistent (i.e. over 14 days duration).
While some cases were clearly persistent, it can be difficult
to distinguish clinically between variation in symptoms
and new episodes of diarrhoea, and it is not clear if the
definition used in children (3 days [10]) applies in HIV
infection. Most episodes of diarrhoea were clearly not per-
sistent, and even cryptosporidiosis, which is strongly asso-
ciated with persistence, was persistent in at most 11% of
incident episodes. One further potential problem arises
from the timing of sample collection. It is possible that
symptoms could have been reported at the end of a
month and the infection only discovered in the next sam-
ple submitted at the beginning of the following month. By
recording symptoms every two weeks we tried to mini-
mise this problem, but it cannot be avoided altogether
and would have the effect of making the association
between symptoms and infections weaker than is really
the case. It would also reduce the estimated disease:infec-
tion ratio but the difference between HIV infected and
uninfected episodes should still be measurable, as indeed
we found.
The assumption that exposure was intense and consistent
in this community underlies our analysis. Infecting dose
has an important influence on clinical manifestations of
intestinal infectious disease [32,33] so intensity of expo-
sure could determine disease-to-infection ratio and sus-
ceptibility. If behavioural factors did play a major role in
determining the incidence of diarrhoea, we might expect
to observe some clustering of incidence in households,
but this was not observed. We were also unable to detect
any influence of boiling of drinking water on diarrhoea
incidence, but as we did not verify the statements made by
respondents against actual observable practices, it is pos-
sible that a small effect may have been missed.
The profile of infections seen in our participants is typical
of the spectrum of pathogens which are seen in African
AIDS patients [18,34], with a preponderance of protozoa.
We did not test for viruses, but we do know that rotavirus
is an extremely rare cause of diarrhoea in Zambian AIDS
patients (P. Kelly, unpublished observations). We have
previously reported the high frequency of isolation of Cit-
robacter rodentium [5].
In this population with an HIV seroprevalence of 31%
and in which 10% of all adults were immunocompro-
mised, the attributable risk of diarrhoea due to HIV (risk
in HIV seropositives minus risk in HIV seronegatives) was
0.312 episodes per year. The population attributable risk
fraction is therefore 28%. It seems likely that the ongoing
expansion of access to anti-retroviral drugs will ameliorate
the increased susceptibility to infection and to disease in
similarly affected populations. In view of the high propor-
tion of asymptomatic infections at all CD4 counts, how-
ever, it seems unlikely that improved cell mediated
immunity in HIV-infected patients treated with anti-retro-
viral drugs will have a significant impact on the transmis-
sion of diarrhoeal pathogens from asymptomatic adults
to other adults and to children. Improved water quality,
sanitation and food hygiene will remain high priorities
for families caring for HIV-infected adults for the foresee-
able future.
Conclusion
HIV infection is associated with an increased disease-to-
infection ratio at all stages of infection and with increased
susceptibility to infection as CD4 count declines. Diar-
rhoeal disease is aggregated in susceptible individuals irre-
spective of CD4 count suggesting that it is not a function
of cell mediated immunity.
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